• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水飞蓟宾补充剂治疗活动期类风湿关节炎:一项初步随机对照临床试验结果。

Silymarin Supplementation in Active Rheumatoid Arthritis: Outcomes of a Pilot Randomized Controlled Clinical Study.

机构信息

Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy, 16, Universitatii Street, 700115 Iasi, Romania.

Clinical Rehabilitation Hospital, 14, Pantelimon Halipa Street, 700661 Iasi, Romania.

出版信息

Medicina (Kaunas). 2024 Jun 18;60(6):999. doi: 10.3390/medicina60060999.

DOI:10.3390/medicina60060999
PMID:38929616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11205411/
Abstract

: Coadministration of natural products to enhance the potency of conventional antirheumatic treatment is of high interest. This study aimed to assess the impact of administration of silymarin (a nutritional supplement) in patients with active rheumatoid arthritis under treatment with conventional disease-modifying antirheumatic drugs. : One-hundred and twenty-two patients diagnosed with active rheumatoid arthritis and treated with conventional disease-modifying antirheumatic drugs were randomly assigned to either control or intervention groups; the latter was supplemented with silymarin (300 mg/day) for 8 weeks. Indicators of disease activity, inflammatory markers, disease activity and disability indices, European League Against Rheumatism responses, fatigue, depression, and anxiety scores were determined at baseline and week 8. : Silymarin supplementation significantly reduced the number of tender and swollen joints, duration of morning stiffness, severity of pain, disease activity and disability indices, European League Against Rheumatism responses, levels of fatigue, depression, and anxiety. According to our results, silymarin substantially improved patients' general condition. : Our study provides evidence for the benefits of silymarin supplementation to disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis.

摘要

联合应用天然产物以增强常规抗风湿治疗的疗效具有重要意义。本研究旨在评估在接受常规疾病修饰抗风湿药物治疗的活动期类风湿关节炎患者中,应用水飞蓟素(一种营养补充剂)的效果。

122 名被诊断患有活动期类风湿关节炎且正在接受常规疾病修饰抗风湿药物治疗的患者被随机分配到对照组或干预组;后者接受水飞蓟素(300mg/天)治疗 8 周。在基线和第 8 周时测定疾病活动的指标、炎症标志物、疾病活动和残疾指数、欧洲抗风湿病联盟反应、疲劳、抑郁和焦虑评分。

水飞蓟素补充治疗显著降低了压痛关节和肿胀关节的数量、晨僵持续时间、疼痛严重程度、疾病活动和残疾指数、欧洲抗风湿病联盟反应、疲劳、抑郁和焦虑评分。根据我们的结果,水飞蓟素显著改善了患者的整体状况。

我们的研究为在活动期类风湿关节炎患者中,水飞蓟素补充治疗对疾病修饰抗风湿药物的益处提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/67c5b154a8d2/medicina-60-00999-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/a52f33596e93/medicina-60-00999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/faa80d09e3c5/medicina-60-00999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/c7112272fb71/medicina-60-00999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/209b2534391f/medicina-60-00999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/c9c51a0aab2f/medicina-60-00999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/67c5b154a8d2/medicina-60-00999-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/a52f33596e93/medicina-60-00999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/faa80d09e3c5/medicina-60-00999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/c7112272fb71/medicina-60-00999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/209b2534391f/medicina-60-00999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/c9c51a0aab2f/medicina-60-00999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0662/11205411/67c5b154a8d2/medicina-60-00999-g006.jpg

相似文献

1
Silymarin Supplementation in Active Rheumatoid Arthritis: Outcomes of a Pilot Randomized Controlled Clinical Study.水飞蓟宾补充剂治疗活动期类风湿关节炎:一项初步随机对照临床试验结果。
Medicina (Kaunas). 2024 Jun 18;60(6):999. doi: 10.3390/medicina60060999.
2
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.司库珠单抗治疗抗 TNF 治疗应答不佳的活动性类风湿关节炎患者的疗效和安全性(SIRROUND-T):一项随机、双盲、安慰剂对照、平行分组、多国、3 期研究。
Lancet. 2017 Mar 25;389(10075):1206-1217. doi: 10.1016/S0140-6736(17)30401-4. Epub 2017 Feb 16.
3
Silymarin (Livergol®) Decreases Disease Activity Score in Patients with Rheumatoid Arthritis: A Non-randomized Single-arm Clinical Trial.水飞蓟素(利肝隆®)降低类风湿关节炎患者的疾病活动评分:一项非随机单臂临床试验
Iran J Allergy Asthma Immunol. 2017 Apr;16(2):99-106.
4
Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study.补充维生素D对改善类风湿关节炎疾病活动度的作用:一项探索性研究。
Int J Rheum Dis. 2017 Jul;20(7):825-831. doi: 10.1111/1756-185X.12770. Epub 2015 Oct 20.
5
Balneotherapy (or spa therapy) for rheumatoid arthritis.类风湿关节炎的温泉疗法(或水疗)
Cochrane Database Syst Rev. 2015 Apr 11;2015(4):CD000518. doi: 10.1002/14651858.CD000518.pub2.
6
Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study.生物制剂类改善病情抗风湿药物在老年类风湿关节炎患者中的安全性和有效性:一项前瞻性队列研究。
Drugs Aging. 2020 Dec;37(12):899-907. doi: 10.1007/s40266-020-00801-x. Epub 2020 Nov 18.
7
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.阿达木单抗、依那西普、英夫利昔单抗、聚乙二醇化赛妥珠单抗、戈利木单抗、托珠单抗和阿巴西普用于治疗既往未使用改善病情抗风湿药物治疗且仅在传统改善病情抗风湿药物治疗失败后的类风湿关节炎:系统评价和经济学评估。
Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350.
8
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.使用托珠单抗抑制白细胞介素-6受体可降低对改善病情抗风湿药物反应不足的类风湿关节炎患者的疾病活动度:托珠单抗联合传统改善病情抗风湿药物治疗研究
Arthritis Rheum. 2008 Oct;58(10):2968-80. doi: 10.1002/art.23940.
9
Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.类风湿关节炎起始队列患者的 20 年结局和早期治疗与死亡率及残疾的相关性:来自诺福克关节炎登记处的结果。
Arthritis Rheumatol. 2017 Aug;69(8):1566-1575. doi: 10.1002/art.40090. Epub 2017 Jul 10.
10
Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis.类风湿关节炎中单药常规抗风湿药或糖皮质激素治疗:网状 Meta 分析。
JAMA Netw Open. 2023 Oct 2;6(10):e2335950. doi: 10.1001/jamanetworkopen.2023.35950.

引用本文的文献

1
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs.天然来源的脂肪酸酰胺水解酶(FAAH)调节剂:新型潜在药物合集
Cells. 2025 Apr 5;14(7):551. doi: 10.3390/cells14070551.

本文引用的文献

1
Silibinin as a major component of milk thistle seed provides promising influences against diabetes and its complications: a systematic review.水飞蓟宾作为奶蓟草种子的主要成分,对糖尿病及其并发症具有显著的防治作用:系统评价。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7531-7549. doi: 10.1007/s00210-024-03172-x. Epub 2024 May 27.
2
Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose-Response Meta-Analysis.水飞蓟素补充剂对心血管危险因素的影响:系统评价与剂量反应荟萃分析。
Antioxidants (Basel). 2024 Mar 24;13(4):390. doi: 10.3390/antiox13040390.
3
Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer's disease.
辅助水飞蓟素补充及其对阿尔茨海默病患者疾病严重程度、氧化应激和炎症的影响。
Nutr Neurosci. 2024 Oct;27(10):1077-1087. doi: 10.1080/1028415X.2023.2301163. Epub 2024 Feb 14.
4
The Impact of Antioxidants on Vitiligo and Melasma: A Scoping Review and Meta-Analysis.抗氧化剂对白癜风和黄褐斑的影响:一项范围综述和荟萃分析。
Antioxidants (Basel). 2023 Dec 6;12(12):2082. doi: 10.3390/antiox12122082.
5
Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up.在 5 年的随访中,出现单关节炎或寡关节炎和高 VAS 评分的类风湿关节炎患者仍然是最疲劳的。
Rheumatology (Oxford). 2024 May 3;63(6):1574-1581. doi: 10.1093/rheumatology/kead429.
6
Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic review.临床实践中治疗类风湿关节炎的疗效比较:系统评价。
Semin Arthritis Rheum. 2023 Oct;62:152249. doi: 10.1016/j.semarthrit.2023.152249. Epub 2023 Aug 6.
7
Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight.水飞蓟素治疗神经疾病患者的药学前景:最新见解
Front Neurosci. 2023 May 18;17:1159806. doi: 10.3389/fnins.2023.1159806. eCollection 2023.
8
The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-α and Interleukin-1ß in Patients with Rheumatoid Arthritis.口服水飞蓟素对类风湿关节炎患者血清肿瘤坏死因子-α和白细胞介素-1β水平的影响。
Iran J Immunol. 2022 Dec;19(4):427-435. doi: 10.22034/IJI.2022.90456.2007.
9
A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas.一项关于局部水飞蓟素与 2%氢醌乳膏治疗黄褐斑的随机、双盲、对照研究。
J Drugs Dermatol. 2022 Dec 1;21(12):1304-1310. doi: 10.36849/JDD.6491.
10
The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies.水飞蓟素/水飞蓟宾对放疗所致毒性的辐射防护潜力:临床与实验研究的系统评价
Curr Med Chem. 2023;30(33):3775-3797. doi: 10.2174/0929867330666221124155339.